University of Alabama at Birmingham
This study evaluates the acceptability and clinical effectiveness of integrating the Nutu™ digital health platform into a comprehensive primary care-based behavioral obesity treatment program using a Zelen randomized controlled trial design.
This pragmatic randomized clinical trial is conducted within the established FLOW program, a 12-month multidisciplinary behavioral obesity treatment aligned with USPSTF recommendations. Patients initiating FLOW are randomized to standard care or FLOW augmented with an offer of Nutu™, an AI-powered digital health platform providing behavioral support and self-monitoring tools. Outcomes are collected quarterly over 12 months using routinely collected clinical data.
Inclusion Criteria: * All patients enrolled in the FLOW clinical program are eligible. Exclusion Criteria: * Not a patient of the FLOW clinical program at UAB.
Participants receive the 12-month FLOW program including nutrition counseling, physician visits, and behavioral health support.
FLOW patients will receive an offer to add the Nutu™ digital health platform to their FLOW treatment plan, which can be accepted or declined. Nutu™ includes features such as AI-powered digital health coaching and food/exercise tracking.
Arctuva estimate
Verify or correct the compensation shown for this listing.